Annual accounts
Total Exemption Full accounts
28/02/2027Filing deadline
Made up to 31/05/2025Due 28/02/2027
- Next accounts made up to
- 31/05/2026
- Last accounts made up to
- 31/05/2025
INTRACT PHARMA LIMITED
Active- 09610219Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- 5 High Green, Great Shelford, Cambridge CB22 5EG
- Classification (SIC)
- Research and experimental development on biotechnology (72.11 - SIC 2007)
- Accounts type
- Total Exemption Full
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 07/09/2026View PDF (2 pages)
Change of details for Dr Vipul Yadiv as a person with significant control on 2026-09-07
- 03/06/2026View PDF (3 pages)
Confirmation statement made on 2026-05-27 with no updates
- 17/04/2026View PDF (3 pages)
Replacement Filing of Confirmation Statement dated 2025-05-27
- 06/02/2026View PDF (12 pages)
Total exemption full accounts made up to 2025-05-31
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
On schedule
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 27/05/2026
- Last statement dated
- 31/05/2025
Financial performance
The latest figures INTRACT PHARMA LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
£1.29M2025
335.30%vs 20242024: £295.92K
Total Assets
£1.51M2025
326.13%vs 20242024: £354.55K
Cash in Bank
£1.35M2025
473.67%vs 20242024: £235.94K
Total Liabilities
£166.11K2025
1.28K%vs 20242024: £12.04K
Employees
92025
+3vs 20242024: 6
Of the 4 measures with an earlier filing to compare against, 4 rose. Total assets moved furthest, up 326.13% on 2024. See the full financial analysis for INTRACT PHARMA LIMITED.
The full financial record
Four ways through INTRACT PHARMA LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · +40.7% a year (CAGR)Three-year trend, 2023–2025Every measure end to end across 2023, 2024 and 2025, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2025.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 5 yearsEvery figure by yearAll 5 measures Okredo tracks across 5 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 9 | +3 |
| 2024 | 6 | -1 |
| 2023 | 7 | -1 |
| 2022 | 8 | +8 |
| 2021 | 0 | – |
Reported employee count increased from 0 in 2021 to 9 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
7Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 04/01/2016–Present | 3 | |
| Director | 28/03/2022–25/04/2022 | 5 | |
| Director | 27/05/2015–26/03/2022 | 5 | |
| Director | 27/05/2015–Present | 2 | |
| Director | 25/11/2015–Present | 12 | |
| Director | 26/03/2022–28/03/2022 | 0 | |
| Director | 25/04/2022–Present | 0 |
Persons with significant control
2Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 25/04/2022–Present | 0 | |
| 06/04/2016–01/05/2022 | 5 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 13 Since 21/10/2022
- Last 12 months
- 4 +3 vs the year before
- Most recent filing
- 07/09/2026 less than a month ago
What changed in the last year
- Officer changesLatest 07/09/2026
- Confirmation statement (2)Latest 03/06/2026
- Accounts filedLatest 06/02/2026
Filing timeline
- 07/09/2026View PDF (2 pages)
Change of details for Dr Vipul Yadiv as a person with significant control on 2026-09-07
- 03/06/2026View PDF (3 pages)
Confirmation statement made on 2026-05-27 with no updates
- 17/04/2026View PDF (3 pages)
Replacement Filing of Confirmation Statement dated 2025-05-27
- 06/02/2026View PDF (12 pages)
Total exemption full accounts made up to 2025-05-31
- 10/06/2025View PDF (4 pages)
Confirmation statement made on 2025-05-27 with no updates
- 04/09/2024View PDF (12 pages)
Total exemption full accounts made up to 2024-05-31
- 16/07/2024View PDF (4 pages)
Confirmation statement made on 2024-05-27 with updates
- 24/01/2024View PDF (10 pages)
Total exemption full accounts made up to 2023-05-31
- 14/08/2023View PDF (3 pages)
Statement of capital following an allotment of shares on 2023-08-04
- 10/07/2023View PDF (4 pages)
Confirmation statement made on 2023-05-27 with updates
- 04/07/2023View PDF (6 pages)
Sub-division of shares on 2023-06-16
- 04/07/2023View PDF (2 pages)
Resolutions
Showing 12 of 13 filings
See when the next accounts and confirmation statement are due
Similar companies
52 UK companies are similar to INTRACT PHARMA LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
OXFORD ENDOVASCULAR LIMITED
Active9400 Garsington Road, Oxford Business Park, Oxford OX4 2HN
- Activity
- Research and experimental development on biotechnology
- Company no.
- 09769779
- Incorporated
- 09/09/2015
- Employees
- 9
AUXETEC LIMITED
ActiveNexus, Discovery Way, Leeds LS2 3AA
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 12925662
- Incorporated
- 03/10/2020
- Employees
- 9
LASER MICROMACHINING LIMITED
Active12-14 Ffordd Richard Davies, St. Asaph Business Park, St. Asaph, Denbighshire LL17 0LJ
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 05288483
- Incorporated
- 16/11/2004
- Employees
- 9
AGUA VIA LIMITED
ActivePaddock Cottage Sandy Lane, Milford, Godalming GU8 5BL
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 06420717
- Incorporated
- 07/11/2007
- Employees
- 10
ALBRIGHT PRODUCT DESIGN LIMITED
ActiveWilliam Burford House, Lansdown Place Lane, Cheltenham GL50 2LB
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 08597948
- Incorporated
- 04/07/2013
- Employees
- 9
About INTRACT PHARMA LIMITED
A short description of the company, written from its Companies House record.
INTRACT PHARMA LIMITED is a private limited company registered in the United Kingdom, based in 5 High Green, Great Shelford, Cambridge CB22 5EG. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 11 years 3 months.
The register currently records it as active. Its 2025 accounts report net assets of £1.29M and 9 employees.
INTRACT PHARMA LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does INTRACT PHARMA LIMITED do?
Companies House records INTRACT PHARMA LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
Is INTRACT PHARMA LIMITED still active?
INTRACT PHARMA LIMITED is recorded as active on the Companies House register, and has been on it since 27/05/2015.
What are INTRACT PHARMA LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2025 and report net assets of £1.29M, total assets of £1.51M, cash in bank of £1.35M and total liabilities of £166.11K.
When did INTRACT PHARMA LIMITED last file with Companies House?
The most recent document on the record is dated 07/09/2026: Change of details for Dr Vipul Yadiv as a person with significant control on 2026-09-07, less than a month ago.
When are INTRACT PHARMA LIMITED's next filings due?
On the current registry record, accounts are due by 28/02/2027.
Who runs INTRACT PHARMA LIMITED?
Companies House lists 7 officers (4 currently in post) and 2 people with significant control (1 current).